Radiotherapy for metastatic prostate cancer

Ana Aparicio; Peter Thall; Christopher Logothetis

doi:10.1016/S0140-6736(19)31783-0

Radiotherapy for metastatic prostate cancer

Ana Aparicio, Peter Thall, Christopher Logothetis

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	829-830
Number of pages	2
Journal	The Lancet
Volume	394
Issue number	10201
DOIs	https://doi.org/10.1016/S0140-6736(19)31783-0
State	Published - Sep 7 2019

ASJC Scopus subject areas

General Medicine

MD Anderson CCSG core facilities

Biostatistics Resource Group

Access to Document

10.1016/S0140-6736(19)31783-0

Cite this

@article{3b3e28a48fa240fb9fd21761160fdacd,

title = "Radiotherapy for metastatic prostate cancer",

author = "Ana Aparicio and Peter Thall and Christopher Logothetis",

year = "2019",

month = sep,

day = "7",

doi = "10.1016/S0140-6736(19)31783-0",

language = "English (US)",

volume = "394",

pages = "829--830",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10201",

}

TY - JOUR

T1 - Radiotherapy for metastatic prostate cancer

AU - Aparicio, Ana

AU - Thall, Peter

AU - Logothetis, Christopher

PY - 2019/9/7

Y1 - 2019/9/7

UR - http://www.scopus.com/inward/record.url?scp=85071731025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071731025&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(19)31783-0

DO - 10.1016/S0140-6736(19)31783-0

M3 - Letter

C2 - 31498098

AN - SCOPUS:85071731025

SN - 0140-6736

VL - 394

SP - 829

EP - 830

JO - The Lancet

JF - The Lancet

IS - 10201

ER -

Radiotherapy for metastatic prostate cancer

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Cite this